Original Research

Published in:
Volume 11 / Year 2022 / Issue 2

A case study of AstraZeneca’s omeprazole/esomeprazole chiral switch strategy

Author(s): ,

Introduction/Objective: To describe the chiral switch, an evergreening strategy used by AstraZeneca to position enantiopure esomeprazole as the new proton pump inhibitor market leader, displacing its predecessor omeprazole. Methodology: A… Read More »

On statistical evaluation for interchangeability of biosimilar products

Author byline as per print journal: Yuqi Li, BS Pharm; Professor Shein-Chung Chow, PhD Abstract: A biosimilar product is a biological product which is highly similar to an existing reference product… Read More »

Development of Ph. Eur. standards for therapeutic monoclonal antibodies: infliximab case study

Keywords: Monoclonal antibodies, pharmacopoeia, infliximab, public standards, flexibility Author byline as per print journal: M Buda, PhD Abstract: This article describes the European Pharmacopoeia exploratory study on infliximab as a test case… Read More »

Go Back Print